- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
Vildagliptin N-Nitroso-L-Proline Methyl Ester
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Vildagliptin medication is used for the treatment of Type 2 diabetes mellitus. This is used along with diet and exercise to improve blood sugar control in adults with Type 2 diabetes. The medication is a type of anti-diabetic drug .Vildagliptin N-Nitroso-L-Proline Methyl Ester is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Vildagliptin N-Nitroso-L-Proline Methyl Ester chemically represented as Methyl Nitroso-L-prolinate . Synchemia is the leading manufacturing and exporter of Vildagliptin N-Nitroso-L-Proline Methyl Ester.We supply Vildagliptin N-Nitroso-L-Proline Methyl Ester with detailed characterization data compliance with regulatory guidelines.
| Product name | Vildagliptin N-Nitroso-L-Proline Methyl Ester |
| SRC CAT No | SRC-N014027 |
| CAS No | 35909-01-4 |
| Mol.F. | C6H10N2O3 |
| Mol.Wt. | 158.2g/mol |
| Related CAS No. | NA |
| Inv Status | In Stock |
